Toxic fungus enlisted in fight against leukemia
Photo:
KATERYNA KON/SCIENCE PHOTO LIBRARY
Researchers say they have been able to modify toxic fungus cells to fight cancer - specifically, leukaemia.
The same mould that has been
linked to deaths
in the excavations of ancient tombs and found on old bread has the capability of fight leukemia cells.
The fungus is known as aspergillus flavus fungus.
Associate professor at the University of Pennsylvania, Dr Sherry Gao, told
Saturday Morning
the discovery was significant.
Gao said they found a new class of compound which was produced by the fungus. But how does the compound fight cancer?
Associate professor at the University of Pennsylvania Dr Sherry Gao.
Photo:
Supplied / Dr Sherry Gao
"We isolated and define the chemical structure of those new compounds," Gao said.
"By making some small chemical tweaks we actually modified the structure a bit, we've found those modified compounds can enter leukaemia cells very selectively.
"Once it's entered the cell, its able to prevent cell division - that's why it could possibly lead to a cure for leukaemia."
This was not the first fungus that has led to a breakthrough in medicine. Penicillin was also created using a fungus.
Gao said her lab was also experimenting with other fungi, aiming to kill other cancer cell lines.
Sign up for Ngā Pitopito Kōrero
,
a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
2 hours ago
- RNZ News
Benadryl: Common allergy medication's risks outweigh its usefulness, experts say
By Asuka Koda , CNN A consumer OTC medicine group notes that products containing diphenhydramine "are not intended for long-term use." Photo: John Nacion/STAR MAX/IPx/AP/File via CNN Newsource Dr Anna Wolfson says she sees dangerous misuse of the allergy medication diphenhydramine in her clinic every day. "If someone has an allergic reaction to a food, people will say, 'Don't worry, I have diphenhydramine in my purse,' and I would say, 'Really, epinephrine is the first-line treatment for food allergies,'" said Wolfson, an allergist at Massachusetts General Hospital. Diphenhydramine can be harmful if people take it after having an allergic reaction to food, she said, because the drug - best known by the brand name Benadryl - makes them drowsy and can cause them to miss signs that their symptoms are getting worse. "It's time to move on. For every single indication that people are using diphenhydramine, there are better drugs that are more effective at treating the symptoms people are trying to treat with fewer side effects," she said. "I've had patients where I worried that diphenhydramine was impairing their ability to drive or fully participate in their daily lives." Wolfson isn't alone in preferring alternatives. In a review published in February, allergy experts from Johns Hopkins University and the University of California, San Diego called for the removal of diphenhydramine from over-the-counter and prescription markets in the United States, saying it's outdated, dangerous and eclipsed by safer alternatives. A first-generation antihistamine approved in 1946, diphenhydramine is widely used for allergies, sleep aid and cold symptoms. It's a common over-the-counter medication in the US, with usage rising in the summer months as people use it to treat itching from bug bites or poison ivy, as well as sneezing and runny nose caused by grass and pollen allergies, according to the American Pharmacists Association. Despite its longstanding presence in American homes, the authors of the new review say it poses disproportionate risks, especially for children and older adults, than newer antihistamines. "Patients should trial alternatives agents like loratadine, which is Claritin, or cetirizine, which is Zyrtec, or fexofenadine, which is Allegra," to alleviate allergy symptoms, Dr. James Clark of the Department of Otolaryngology-Head and Neck Surgery at the Johns Hopkins University School of Medicine, the lead author of the paper, told CNN. The Consumer Healthcare Products Association, which represents the OTC medicine industry, says that common side effects associated with products containing diphenhydramine are disclosed on the label. However, it notes, "these products are not intended for long-term use". "When used as directed, these medicines provide well-established therapeutic benefits for common health ailments like allergies, the common cold, motion sickness, minor skin irritations, and occasional sleeplessness," the group said in a statement on behalf of Benadryl's maker, Kenvue. "Like all medicines, responsible use is essential, and consumers should always follow directions and warnings on the Drug Facts labels and consult healthcare providers if they have questions." Antihistamines work by blocking receptors called H1, part of the body's system for responding to allergens, which trigger symptoms like sneezing, itching and a runny nose. But older drugs like diphenhydramine don't just block the allergy-related receptors, they can also affect other parts of the brain. Diphenhydramine often causes sedation, cognitive impairment, and in some cases, dangerous cardiac effects, the authors wrote. In older adults, the drug can stay in the body for up to 18 hours, resulting in lingering sleepiness, disorientation and increasing risk of falling. The review also highlighted a possible link between long-term diphenhydramine use and dementia . In children, the risks can be even more pronounced. The review's authors cite cases of accidental overdose; paradoxical reactions such as agitation, extreme sedation and coma; and even death, particularly with pediatric formulations, because of accidental ingestions. The medication was linked to several child hospitalisations and fatalities during the viral "Benadryl Challenge" on TikTok. Dr Manuela Murray, director of general pediatrics and urgent care at the University of Texas Medical Branch, says diphenhydramine "should not be used lightly". "It should always be used under the guidance of a Medical Professional, and it is only indicated to treat allergic reactions and motion sickness," Murray wrote in an email. The medication is often misused and " doesn't offer a benefit for treatment of cold symptoms , and it is not a safe sleep aid medication," she said. In fact, it can have the opposite effects in children, leading to hyperactivity. Dr Alyssa Kuban, a pediatrician and associate medical director at Texas Children's Pediatrics, also said that she finds diphenhydramine overused for symptoms it does not directly treat and that there are safer alternatives. "I see some families use diphenhydramine when the child has a cold or upper respiratory infection, thinking it will help with the congestion and help them to sleep better at night," she said. "This is not effective for cold symptoms, nor is it very safe." She recommends over-the-counter cetirizine to treat children with hives, seasonal allergies or an itchy rash. Cetirizine is also longer-lasting and not as sedating as diphenhydramine, she says. Murray agrees that loratadine and cetirizine are safer for children over 6 months, and saline drops and suctioning are better alternatives for infants. Diphenhydramine appears in over 300 OTC formulations, often blended into combination products for coughs, colds and flu. The authors of the review say that, like products with pseudoephedrine, diphenhydramine should at minimum be moved behind the counter, allowing pharmacists to guide patients toward second-generation alternatives. The American Pharmacists Association says patients should use caution with combination cough and cold products that contain diphenhydramine. Pharmacists may recommend alternative medications for older adults who have a history of being cognitively affected by certain medications, the group says, and it "encourages patients and parents/caregivers to ask their pharmacist for the most appropriate treatment recommendation for their symptoms" with the least amount of side effects. The review authors also emphasise that there is no strong clinical data that may suggest that diphenhydramine works better than other options. Although it may reduce symptoms like sneezing and itching, it has minimal effect on nasal congestion and doesn't outperform second-generation drugs in randomized trials. Newer options, such as oral cetirizine, offer 24-hour coverage with fewer adverse events. However, in the US, the medication remains a staple. According to the review, more than 1.5 million prescriptions are still written annually, not counting untracked OTC purchases. "In the past, it has been a useful medication that has helped millions of patients; however, its current therapeutic ratio is matched or exceeded by second-generation antihistamines, especially due to their markedly reduced adverse reactions. It is time to say a final goodbye to diphenhydramine, a public health hazard," the authors wrote. - CNN
RNZ News
15 hours ago
- RNZ News
‘Megaflash' lightning bolt travelled over 800 kilometres, setting a new record, study says
By Tyler Ory , CNN Megaflashes are rare - with fewer than one percent of thunderstorms producing them. (File photo) Photo: Unsplash/ Rahul Viswanath Lightning is a familiar sight in stormy skies, but a new report has revealed just how far some bolts can travel - in one case, more than 500 miles (800 km). That astonishing bolt sparked to life in eastern Texas and stretched all the way to Kansas City, Missouri, travelling 515 miles (828 km) in seconds. It struck during a thunderstorm in October 2017, but the bolt's exact distance was finally verified in the study, published Thursday in the Bulletin of the American Meteorological Society. "We call it megaflash lightning and we're just now figuring out the mechanics of how and why it occurs," said Randy Cerveny, one of the study's authors and a professor of geographical sciences at Arizona State University. Researchers discovered the record-breaking megaflash while re-evaluating satellite data with new computational methods. The data from the satellites also provided much greater detail than previous observations, letting scientists determine individual megaflashes in these past storms. "Flashes at this extreme scale always existed, and are now becoming identifiable as our detection capabilities and data processing methods improve," the paper says. It's helping scientists and forecasters better understand what lightning is capable of and the dangers it poses. All lightning is an electric discharge - much like a static shock, just on a larger scale. Inside a thunderstorm, ice and water particles collide and exchange electrons, creating a buildup of electric charge. Lightning occurs when that charge becomes too strong for the atmosphere to hold onto and discharges it in the form of a bolt either through the cloud or down to the ground. Most lightning stays within 10 miles (16 km) of the storm where it originated. When it travels more than 60 miles (96 km), it's considered a megaflash. Michael Peterson, the report's lead author and a senior scientist at Georgia Institute of Technology's Severe Storms Research Center, said megaflashes tend to form in the weaker, outer parts of a storm system - not the intense core most people associate with lightning - and often after the storm has moved on. The record-breaking 2017 flash followed that same pattern, creeping through the broad cloud layers that trailed a cold front across the southern Plains. Flat, sheet-like clouds stretching from Texas to Kansas City formed a shallow layer that could easily conduct electricity - creating ideal conditions for lightning to travel horizontally for hundreds of miles (km). As the megaflash travels through the clouds, it can shoot off multiple ground-striking bolts. "You might have an entire thunderstorm's worth of lightning, cloud to ground strokes, in one flash," Peterson noted. Megaflashes are rare: Fewer than 1 percent of thunderstorms produce them, according to satellite data analysed by Peterson in the study. The storms that do are also generally long-lived and massive, covering thousands of square miles. That expansiveness is key, Peterson said, and is likely "the primary driver" of megaflashes, as smaller storms can't support as much horizontal travel. "But the thing is that we don't actually know exactly what sets of conditions actually allow these flashes to occur at these scales," Peterson added. The 2017 megaflash may be the longest ever verified, now beating out a bolt of 477 miles (767 km) in April 2020, but scientists don't expect it to hold that title for long. "Oh, we'll find more," Cerveny said. "We are still in the process of evaluating data." The satellite-based lightning mappers that made this discovery possible have only been operation for about 10 years - a short window in climate science terms - and there's a lot more data to analyse. The tools used to track extreme events like the Texas-to-Missouri bolt are opening new frontiers in lightning research, said Chris Vagasky, a meteorologist with the National Lightning Safety Council who was not involved in the study. "What I'm looking forward to is seeing how does the location of where lightning occurs change?" Vagasky said. "It is going to be really useful from having all of these datasets, ground-based or satellite- based, to help us really understand what is going on with lightning and thunderstorms." While megaflashes are rare, their risks are very real. Peterson said they represent a kind of worst-case lightning scenario: Powerful discharges capable of sparking wildfires or causing damage far from a storm's core. "You don't see where they come from. You only see where they strike," Peterson said. "The extent of the hazard and then the fact that it's unexpected both contribute to why it's important to understand for public safety." Many lightning injuries happen because people underestimate how far a bolt can actually travel from a storm and how long the danger can linger. Cerveny, too, emphasized the importance of correcting the misconception that lightning can strike "out of the blue." "These megaflashes really point out one of the severe problems that is associated with thunderstorms," said Cerveny. "A lightning flash can start in a thunderstorm very far away, and travel, as we've just shown, 500 miles (800 km) before it ends." - CNN
RNZ News
3 days ago
- RNZ News
Magnitude 8 quake strikes near Russia, NZ assessing tsunami risk
The National Emergency Management Agency and GNS Science are currently assessing whether an earthquake off the Russian coast could create a tsunami affecting New Zealand. The magnitude 8 earthquake struck 74 kilometres deep off the eastern coast of Russia. If a tsunami has been generated in this location it is not likely to arrive in New Zealand for at least 12 hours, it said.. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
